Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amifampridine modified-release pharmacokinetic and pharmacodynamic study in LEMS
NL-OMON56948Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of amifampridine in Lambert-Eaton myasthenic syndrome (LEMS), sponsored by Leiden University Medical Center. Primary endpoints: Tmax, Cmax and 3 more. Started Mar 2026; status: recruiting.
02
Drugs
amifampridine
03
Conditions
Lambert-Eaton myasthenic syndrome (LEMS)
Beyond the preview
Go deeper on NL-OMON56948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56948.